0
0.0
tv
eye 0
favorite 0
quote 0
those two the together -- amgen. they're dow stocks. those two together account for 318 points for the dow industrials. lauren: wow. stuart: take those two out and overstill got a 200-point gain for the dow. am amgen, they are up as of now $39 a sharaf hair report. they're rivals to eli lilly and -- lauren: weight loss drugs. they've got one. actually, they just scrapped one of them. it's their weight loss pill. thought that would be so easy, right in take a pill -- stuart: yeah, a winner. lauren: are the trial data wasn't so good, so now they're doubling down on their weight loss shot. it's taken once a month, so less frequently, and it helps keep the weight off -- stuart: you've got that look on your face, bahnsen. >> we're huge shareholders of amgen. i don't think they've scrapped the weight loss bill -- pill, i think they're focus on the injection side. but there's not going to be an a duopoly here. eli lilly down quite a bit today, they've had the full run are on these weight loss pills. again, amgen still has to go to stage three,
those two the together -- amgen. they're dow stocks. those two together account for 318 points for the dow industrials. lauren: wow. stuart: take those two out and overstill got a 200-point gain for the dow. am amgen, they are up as of now $39 a sharaf hair report. they're rivals to eli lilly and -- lauren: weight loss drugs. they've got one. actually, they just scrapped one of them. it's their weight loss pill. thought that would be so easy, right in take a pill -- stuart: yeah, a winner....
0
0.0
May 3, 2024
05/24
by
CNBC
tv
eye 0
favorite 0
quote 0
and amgen, pretty cheap stock, pretty sleepy story for a long time. and you get a little bit of this hope in this stock that it might be a player in this area. and you see the result. we have made the comparison before, but it is like when boring old broadcom became an a.i. play and there was room for expansion as long as that story seems credible. >> all right, seema, you sat here on post nine and told us what to look out for, from both of these reports yesterday. now they delivered stocks in opposite directions, why? >> there is two reasons behind this outperformance that booking is seeing. it is aggressive spend on marketing at a time when expedia pulled back, really allowing it to gain market share in the home rental category. expedia is experiencing a slower than expected recovery. booking also pivoted into international at the right time. they're seeing china, japan, europe sales increase, this is a region -- country specifically where expedia has less of a presence. this is the last quarter for peter kearn who led expedia since 2020. still a nu
and amgen, pretty cheap stock, pretty sleepy story for a long time. and you get a little bit of this hope in this stock that it might be a player in this area. and you see the result. we have made the comparison before, but it is like when boring old broadcom became an a.i. play and there was room for expansion as long as that story seems credible. >> all right, seema, you sat here on post nine and told us what to look out for, from both of these reports yesterday. now they delivered...
0
0.0
May 15, 2024
05/24
by
CNBC
tv
eye 0
favorite 0
quote 0
amgen and merck. why? >> you add further exposure in what is a bull market and you're looking within your portfolio and saying to yourself where, in fact, can i add that exposure? health care going back to sentiment and positioning, it could be rebuilt higher. i also think that what we're witnessing in some of the consumer oriented names, like mcdonald's, like starbucks, like home depot, those investors are going to be moving into health care oriented names looking for a little bit of the bond proxy, which the bond proxy is back today, and also a little bit more of a defensive structure. now understand health care overall had difficult numbers because of covid. now working away from those come ms and the two names that i bought early this morng, believe are best in breed. merck clearly is a name i've owned for years in the past, moved away from. and in the case of amgen, this is large tech, bioexposure. go back to sentiment. it's remarkable. only 54% of the analyst community have buy ratings. the price is
amgen and merck. why? >> you add further exposure in what is a bull market and you're looking within your portfolio and saying to yourself where, in fact, can i add that exposure? health care going back to sentiment and positioning, it could be rebuilt higher. i also think that what we're witnessing in some of the consumer oriented names, like mcdonald's, like starbucks, like home depot, those investors are going to be moving into health care oriented names looking for a little bit of the...
0
0.0
May 3, 2024
05/24
by
CNBC
tv
eye 0
favorite 0
quote 0
. >>> amgen soaring. the company goes all in on an injectable weight loss dg.ru kevin owns the stock. we'll get his take next. to new adventures. -oh. mwah. -planned... -and unplanned. -surprise! -they lead to goals. -for you, mama. and connect us to family. i didn't get the part. your dedicated fidelity advisor can help you open those doors. but i did get waiter number 2. because they know you. they can help you create a comprehensive plan for your full financial picture and personalized money management with the right balance of risk and reward. doors were meant to be opened. ♪ >>> welcome back. take a look at amgen soaring today. the company announcing it's moving forward with an injectable obesity drug. it's really soaring on that drug trial result, and you own the stock. can you give us context here? >> even we were pleasantly surprised with the stock price move. apple was great. looking at amgen, this stock is up 15%. they're a limb bit late to the party on the obesity drug admittedly, but they're
. >>> amgen soaring. the company goes all in on an injectable weight loss dg.ru kevin owns the stock. we'll get his take next. to new adventures. -oh. mwah. -planned... -and unplanned. -surprise! -they lead to goals. -for you, mama. and connect us to family. i didn't get the part. your dedicated fidelity advisor can help you open those doors. but i did get waiter number 2. because they know you. they can help you create a comprehensive plan for your full financial picture and...
0
0.0
May 2, 2024
05/24
by
CNBC
tv
eye 0
favorite 0
quote 0
>> sure. >> and he was right about amgen. the last time he was on, $318 stock, traded down to $280, right back where it is he's been spot on the entire space. i'll say this real quick, personally, i think amgen at 15 times is too cheap it's had fits and starts to the upside, but there will be excitement around, the market will try to get ahead of it. >>> coming up, coinbase, block, draftkings and more. >>> plus, prepping for payrolls. markets turning their attention from yesterday's fed meeting to tomorrow's jobs report how should you position yourself heading into the weekend you're watching "fast money" live from the nasdaq market site in times square. ckig aerhiba rhtft ts.gan stan te untapped possibilities and relentlessly work with you to make them real. >>> welcome back we're getting details from the apple conference call. the cfo saying he expects june quarter revenue to grew low single digits, even with the foreign exchange headwind of 2.5 percentage points. services expected to grow double digits, similar to what the
>> sure. >> and he was right about amgen. the last time he was on, $318 stock, traded down to $280, right back where it is he's been spot on the entire space. i'll say this real quick, personally, i think amgen at 15 times is too cheap it's had fits and starts to the upside, but there will be excitement around, the market will try to get ahead of it. >>> coming up, coinbase, block, draftkings and more. >>> plus, prepping for payrolls. markets turning their...
0
0.0
May 3, 2024
05/24
by
CNBC
tv
eye 0
favorite 0
quote 0
amgen is also saying it will scrap an experimental pill. it's going all in on this drug and earlier drugs in the pipeline. >> i'll pick it up from here. thank you very much for breaking it down for us. appreciate it. >>> let's turn to the bond market now when yields took a sharp dip lower on the jobs data. let's get to rick santelli with that data. rick? >> yes. not only do i have a special gu guest, but today's jobs number was less than expected. the interest rates along the curve went lower, but they have since borm bottomed and the reason they bottomed is my guest. jim bianco. we haven't had a live interview with over four years. welcome back. what are your thoughts about the jobs market? >> good to be back. the jobs market were good for the market. it showed that, you know, the restraint that everybody thought backed off -- we've got jobs, but not too many jobs. probably the best part of the report was labor costs fell two-tenths up and on a year over year basis, they're down 4%. the market got what it wanted. it got growth and backing
amgen is also saying it will scrap an experimental pill. it's going all in on this drug and earlier drugs in the pipeline. >> i'll pick it up from here. thank you very much for breaking it down for us. appreciate it. >>> let's turn to the bond market now when yields took a sharp dip lower on the jobs data. let's get to rick santelli with that data. rick? >> yes. not only do i have a special gu guest, but today's jobs number was less than expected. the interest rates along...
0
0.0
May 3, 2024
05/24
by
CNBC
tv
eye 0
favorite 0
quote 0
i think amgen should have been up, and remember, amgen was up in january when they said this, and then we got the numbers and eli lilly turned out to be doing really well. let lilly come down and buy a bundle. >> jim, let's get the opening bell here. at the big board, it is the consulate general of mexico in new york. cinco de mayo is this sunday. at the nasdaq, it's the committee to protect journalists. speak of amgen. that's going to be the lion's share of the dow. >>mgen is a great company, and bradway is a serious executive. they have an anti-cholesterol drug that's still not getting its due. they have a terrific migraine drug that is not getting its due. and all i can tell you is that they're a juggernaut that people don't think is a juggernaut, and their dow stock that everyone was unexcited about, but they and pfizer are the two drug stocks that are suddenly in the conversation again. and i think it's important to point out that pfizer may have some momentum too. >> yeah, huge weight in the dow, even before the jobs number was going to account for a couple hundred points of gain
i think amgen should have been up, and remember, amgen was up in january when they said this, and then we got the numbers and eli lilly turned out to be doing really well. let lilly come down and buy a bundle. >> jim, let's get the opening bell here. at the big board, it is the consulate general of mexico in new york. cinco de mayo is this sunday. at the nasdaq, it's the committee to protect journalists. speak of amgen. that's going to be the lion's share of the dow. >>mgen is a...
0
0.0
May 8, 2024
05/24
by
CNBC
tv
eye 0
favorite 0
quote 0
, it's interesting that we've looked at amgen. what i find most exciting, not that it's once a month, but if it works the way they are studying it, you don't have to take it for the rest of your life, and that, to me, is what all providers are looking for. the cost of people being on the drugs forever is just astronomical and unavailable yes, i think there are a lot of health care sites that are down. they may not be cheap because many are binary. whether they work or don't work. and so you have to take maybe a basket approach and, therefore, you kind of lower your risk on each one of them because if the phase three doesn't work, the stock goes down 80%. >> not all health care related stocks are created equal not even in apples and oranges united health you think is on sale. >> definitely on sale. this stock got hit by a cyber attack that is going to work its way through the system and still the leader in the field, we think it's a cheap stock on earnings it has a great balance sheet it's continuing to grow. so, yes, we do like th
, it's interesting that we've looked at amgen. what i find most exciting, not that it's once a month, but if it works the way they are studying it, you don't have to take it for the rest of your life, and that, to me, is what all providers are looking for. the cost of people being on the drugs forever is just astronomical and unavailable yes, i think there are a lot of health care sites that are down. they may not be cheap because many are binary. whether they work or don't work. and so you...
0
0.0
May 3, 2024
05/24
by
CNBC
tv
eye 0
favorite 0
quote 0
amgen doubling down. the stock is surging. >>> all buffett all the time as we tee it up for the annual shareholder meeting. it is friday, may 3rd, 20t24. you are watching "worldwide exchange" here on cnbc. >>> good morning and welcome to "worldwide exchange." we are coming to you live from cnbc london. let's kickoff the hour with the stock futures after a positive session for stocks yesterday. the dow posted the best day since late march and nasdaq closed higher by more than 1%. it is all about the dow. the dow looking like it would open up 250 points higher. we cannot talk about the futures without talking about apple. shares are rallying in the pre-market and accounting for 65 points. the dow pre-market gains with apple shares up 6%. a blowout report. record share buyback. we will talk more about apple in a moment. we getting saet for the april jobs report to see if the fed can begin their easing campaign sooner than later. non-farm payrolls to come in at 240,000. look at the treasuries. the benchmark a
amgen doubling down. the stock is surging. >>> all buffett all the time as we tee it up for the annual shareholder meeting. it is friday, may 3rd, 20t24. you are watching "worldwide exchange" here on cnbc. >>> good morning and welcome to "worldwide exchange." we are coming to you live from cnbc london. let's kickoff the hour with the stock futures after a positive session for stocks yesterday. the dow posted the best day since late march and nasdaq closed...
0
0.0
tv
eye 0
favorite 0
quote 0
your morning mover amgen stock is up in the premarket, the drug manufacturer soaring on optimism over early data from the obesity treatment trial, amgen is scrapping the weight loss pill and instead moving forward with an injectable drug just like the others on the market right now like ozempic and mounjaro, reported the double be on warnings of gravity for the first quarter probably get a profit from the merger with horizon therapeutics amgen is on track to boost the dow at the open, the stock is up 21% in the last year, this morning tacking on a 14% move right now and amgen, gop senators are pushing back a president biden's plan to relocate palestinian refugees into america house judiciary ben cline is here with thoughts on that in the white house plan. stay with us. ♪ sho ♪ innovation in health care means nothing if no one can afford it. ♪ at evernorth, we're helping to unlock barriers. ♪ using our 35 plus years of pharmacy benefits management experience to save businesses billions while boosting medication adherence. helping plan sponsors and their members be at their best
your morning mover amgen stock is up in the premarket, the drug manufacturer soaring on optimism over early data from the obesity treatment trial, amgen is scrapping the weight loss pill and instead moving forward with an injectable drug just like the others on the market right now like ozempic and mounjaro, reported the double be on warnings of gravity for the first quarter probably get a profit from the merger with horizon therapeutics amgen is on track to boost the dow at the open, the stock...
0
0.0
tv
eye 0
favorite 0
quote 0
if amgen up almost 13%. stuart: how about estee lauder? lauren: down 10% this week, they gave a weak second half outlook, and they got a downgrade today at morgan stanley. they go to neutral. stuart: williams-sonoma a? lauren: upgrade to neutral with a price target of 27. 5 -- stuart: wait a minute, it's at 304 -- lauren: yeah. their commentary was good, will. yams sonoma is the home of picety spatulas, i always go for mid salad tongs. they're more money, but they work. if you look at the home furnishings category, in general it's improving especially out west. stuart: stock's up 4%, $300 a share. all right, take it. >>> coming up, a new report ea veal ises billions of dollars from mideastern countries have gone towards temperature funding our colleges. is that what's helping fuel the anti-semitech and anti-american protests? we're going to dig into it nor you. >>> trump is hosting a republican donor event in palm beach this weekend. a number of his potential vice presidential picks are are expected to attended. we'll bring you the list. >
if amgen up almost 13%. stuart: how about estee lauder? lauren: down 10% this week, they gave a weak second half outlook, and they got a downgrade today at morgan stanley. they go to neutral. stuart: williams-sonoma a? lauren: upgrade to neutral with a price target of 27. 5 -- stuart: wait a minute, it's at 304 -- lauren: yeah. their commentary was good, will. yams sonoma is the home of picety spatulas, i always go for mid salad tongs. they're more money, but they work. if you look at the home...
0
0.0
May 16, 2024
05/24
by
CNBC
tv
eye 0
favorite 0
quote 0
if you look at amgen, low single digits earnings and sales growth next year. if this drug does come to market, it has to get rerated. it's trading at 15 1/2 times. >> and in terms of back to roche, i mean, it hasn't really rerated. you had the kind of a move today, you've seen a little bit of momentum in the stock, but the stock is still 16, 17 times, and that puts it very much in value territory. >> the weight loss drug craze taking over pop culture now. paramount plus announcing its latest south park special will tackle the subject head-on. >> there's new crazy drugs people are doing. >> have you heard of semiblew tide. >> cartman, this could be dangerous. >> let's do it. >> so, what does this tell you about the mainstream of ozempic and other drugs? >> bigger addressable market. >> totally. >> it's absolutely become part of not only the psyche, but it's absolutely part of the mainstream. and it's not just for people who are obese anymore. >> not going to believe me -- >> you have no idea what that is. >> honestly. >> you don't know what south park is, you n
if you look at amgen, low single digits earnings and sales growth next year. if this drug does come to market, it has to get rerated. it's trading at 15 1/2 times. >> and in terms of back to roche, i mean, it hasn't really rerated. you had the kind of a move today, you've seen a little bit of momentum in the stock, but the stock is still 16, 17 times, and that puts it very much in value territory. >> the weight loss drug craze taking over pop culture now. paramount plus announcing...
0
0.0
May 3, 2024
05/24
by
CNBC
tv
eye 0
favorite 0
quote 0
shares of amgen soaring getting into the business. number one, the company said it will stop developing its experimental weight loss pill and move forward with the injectable drug. the company will release initial data from the midstage trial on that drug. it is pleased with the results so far. the injection is different from existing drugs liking wegovy and zepbound which activist a gut hormone receptor. amgen's drug blocks the receptor which changes how the body breaks down sugar and helps keep weight off after they stop taking it. that is the worry of the others. it has been tested to be taken once a month or even less frequently. that's the amgen news. >> a friend of mine ran into me last night. i'm at a cocktail party. i'm eating with no discipline right off the appetizers. >> you look like you have been cov gorging. >> he said you are really going to take ozempic? >> he looked at you. >> i think that there's going to be a microscopic version that people will take. >> what will it do? >> it is all about addiction. >> you will get
shares of amgen soaring getting into the business. number one, the company said it will stop developing its experimental weight loss pill and move forward with the injectable drug. the company will release initial data from the midstage trial on that drug. it is pleased with the results so far. the injection is different from existing drugs liking wegovy and zepbound which activist a gut hormone receptor. amgen's drug blocks the receptor which changes how the body breaks down sugar and helps...
0
0.0
May 3, 2024
05/24
by
BLOOMBERG
tv
eye 0
favorite 0
quote 0
amgen is up more than 12% on the day. the job support misses putting a 20 24 interest rate cut back in play for the fed according to investors. mike mckee asked the former st. louis fed president jim bullard about the fight against inflation in the wake of the jobs miss. >> it's a good problem to have. the committee has been very successful. the economy is growing at a good pace. the labor market is very strong in today's report, a little softer than the last time. but still a very solid report. inflation is above target, but mark -- not nearly as much as it was. most people think it will head back to target going forward. >> for more let's bring in the pimco chief u.s. economist tiffany wilding. it is kind of like a national holiday these days for bond traders looking at the bond support. when you saw softeners in the labor market it was pretty stark relative to what expectations were on the consensus. when you see this weakening, what is the risk things we can at a faster pace than people expect? >> it is funny. when we
amgen is up more than 12% on the day. the job support misses putting a 20 24 interest rate cut back in play for the fed according to investors. mike mckee asked the former st. louis fed president jim bullard about the fight against inflation in the wake of the jobs miss. >> it's a good problem to have. the committee has been very successful. the economy is growing at a good pace. the labor market is very strong in today's report, a little softer than the last time. but still a very solid...
0
0.0
tv
eye 0
favorite 0
quote 0
we've got the one showing the most muscle, that is amgen up 11%. pharmaceutical giant getting quite a major boost. today on promising interim results of mid stage trialing of weight loss drug meritide and injectable for obese or overweight adults without diabetes and amgen working with regulators for a late stage trial and possibly entry into the market is sending major players like eli lilly, maker of zepbound down 1.2% and novo nordisk maker of wegovy down half a percent. in the last few months, gyms have warned they're seeing lower attendance, wal-mart said its customers on ozempic are buying less oturu grocery stores and gnc wants to capitalize on the shifts and the nutrition company launched a new strategy to cater to gl1 users and a wall of supplements in their stores with 200 products that they believe will appeal to those on the drugs. ceo michael costello joining us live from the gnc store in derby, kansas. michael, how are you evolving retail stores in space and more. >> they've been helping consumers live well and gnc is a new trend and
we've got the one showing the most muscle, that is amgen up 11%. pharmaceutical giant getting quite a major boost. today on promising interim results of mid stage trialing of weight loss drug meritide and injectable for obese or overweight adults without diabetes and amgen working with regulators for a late stage trial and possibly entry into the market is sending major players like eli lilly, maker of zepbound down 1.2% and novo nordisk maker of wegovy down half a percent. in the last few...
0
0.0
May 3, 2024
05/24
by
CNBC
tv
eye 0
favorite 0
quote 0
earnings report driving, this and apple and amgen both dow components. about 80 points for the dow is coming just from apple and even more so from amgen, moving around 270 points of the dow's move today. so keep an eye on those particular stocks. weight loss plays a part in that story. we'll talk more about both later on. and the ten-year note yield, we want to show you what happened around 8:30 a.m. even time with a report that came out for jobs. you can see that sharp drop in terms of long-term yields going over there, about 4.758% going back 24 hours in a drop all the way kind of down towards that 4.45 range so far today. back up to 4.51. but that rate story is a big deal for a lot of traders out there. that's where we begin, with today's cooler than expected jobs report, the big question now for investors is whether it's enough to move the needle on when the fed will begin cutting interest rates. steve liesman has been all over the story, and he's got a closer look at the numbers. we saw the market reaction. take us through the story about what happe
earnings report driving, this and apple and amgen both dow components. about 80 points for the dow is coming just from apple and even more so from amgen, moving around 270 points of the dow's move today. so keep an eye on those particular stocks. weight loss plays a part in that story. we'll talk more about both later on. and the ten-year note yield, we want to show you what happened around 8:30 a.m. even time with a report that came out for jobs. you can see that sharp drop in terms of...
0
0.0
May 17, 2024
05/24
by
CNBC
tv
eye 0
favorite 0
quote 0
. >>> and fda approving amgen therapy for a cancer drug. this is a second or later line treatment. meaning patients can take it if their cancer progresses while on or after trying another form of treatment. amgen says it will continue pursuing other studies that could allow the drug to be used as a first line treatment. >>> and reuters says shanghai d not have security assessments. companies such as tesla have been lobbying china to allow cross border sharing of information after beijing first tie-in data controls in 2022. >> thank you very much. >>> and coming up, copper conundrum. risks around the metals rapid rise and whether a meltdown could spill over in on broader markets. icy hot. ice works fast. ♪♪ heat makes it last. feel the power of contrast therapy. ♪♪ so you can rise from pain. icy hot. >>> welcome back to "worldwide exchange." turning to the commodities complex and specifically copper. prices for the metal here in the u.s. hovering near all-time highs crossing above the $5 mark earlier this week. u.s. prices have surged to a record premium over the global benc
. >>> and fda approving amgen therapy for a cancer drug. this is a second or later line treatment. meaning patients can take it if their cancer progresses while on or after trying another form of treatment. amgen says it will continue pursuing other studies that could allow the drug to be used as a first line treatment. >>> and reuters says shanghai d not have security assessments. companies such as tesla have been lobbying china to allow cross border sharing of information...
0
0.0
tv
eye 0
favorite 0
quote 0
caterpillar, amazon, amgen and they're all winners on the dow. missouri attorney general wants the justice department to hand over all communications to investigating or prosecuting donald trump. were these prosecutions coordinated by the department of justice? that's a no no. we'll ask the missouri attorney general, next. ♪ lauren: duo lingo is down and they grew daily active users to over 30 million and the issue is they're growing at slower expirate stock's down despite raising guidance fors year. we haven't heard that from any companies but it's a severe reaction. stuart: another stock selling off sharply is roblox. lauren: yeah, dialed back current quarter revenue guidance and not just us saying it looks severe but web bush saying it's a harsh reaction to numbers not terrible and wall street e xpecting more from companies in an economy they see being uncertain or slowing down. stuart: two republican officials are urging the department of justice to investigate ex-trump attorney michael cohen. why, ashley. can you tell us? ashley: yeah, hou
caterpillar, amazon, amgen and they're all winners on the dow. missouri attorney general wants the justice department to hand over all communications to investigating or prosecuting donald trump. were these prosecutions coordinated by the department of justice? that's a no no. we'll ask the missouri attorney general, next. ♪ lauren: duo lingo is down and they grew daily active users to over 30 million and the issue is they're growing at slower expirate stock's down despite raising guidance...
0
0.0
May 3, 2024
05/24
by
BLOOMBERG
tv
eye 0
favorite 0
quote 0
you can think apple, amgen, and bookings. coming up on blumer technology, i'm going to be speaking with the coinbase ceo, alongside ed ludlow. we are looking forward to that conversation. that does it for bloomberg markets. stick with us. a busy day into the close. big moves in the bond market. ♪ (♪♪) (♪♪) what took you so long? i'm sorry, there was a long line at the thai place. you get the sauce i like? of course! you're the man! i wish. the future isn't scary. not investing in it is. nasdaq-100 innovators. one etf. before investing, carefully read and consider fund investment objectives, risks, charges, expenses and more in prospectus at invesco.com and they're all coming? investment objectives, rithose who are stillses with us, yes. grandpa! what's this? your wings. light 'em up! gentlemen, it's a beautiful... ...day to fly. >> the heart of where money, innovation, and power collide in silicon valley and beyond, this is "bloomberg technology" with ed ludlow and caroline hyde. ed: i'm ed ludlow in san francisco.
you can think apple, amgen, and bookings. coming up on blumer technology, i'm going to be speaking with the coinbase ceo, alongside ed ludlow. we are looking forward to that conversation. that does it for bloomberg markets. stick with us. a busy day into the close. big moves in the bond market. ♪ (♪♪) (♪♪) what took you so long? i'm sorry, there was a long line at the thai place. you get the sauce i like? of course! you're the man! i wish. the future isn't scary. not investing in it...
0
0.0
May 2, 2024
05/24
by
CNBC
tv
eye 0
favorite 0
quote 0
the consumer wants to do with their capital and that's not changing any time soon either. >> ryan, amgen is after the bell today. >> we've owned it for ten years. this used to be the go-to biotech stock. it's done an amazing job moving from just a pipeline stock to a pure driven in terms of what they're putting out. >> we'll take a break, come back and do "finals" next trading at schwab is now powered by ameritrade, unlocking the power of thinkorswim, the award-winning trading platforms. bring your trades into focus on thinkorswim desktop with robust charting and analysis tools, including over 400 technical studies. tailor the platforms to your unique needs with nearly endless customization. and track market trends with up-to-the-minute news and insights. trade brilliantly with schwab. [crowd chanting] they ignored your potential, and mocked your ambition. but it's not the critic who counts. with every swing and block, your game plan never changed. ♪♪ some still call it luck. let them. because you know what it's always been. inevitable. ♪♪ ♪♪ nice to meet ya. my name is david
the consumer wants to do with their capital and that's not changing any time soon either. >> ryan, amgen is after the bell today. >> we've owned it for ten years. this used to be the go-to biotech stock. it's done an amazing job moving from just a pipeline stock to a pure driven in terms of what they're putting out. >> we'll take a break, come back and do "finals" next trading at schwab is now powered by ameritrade, unlocking the power of thinkorswim, the...
0
0.0
May 17, 2024
05/24
by
CNBC
tv
eye 0
favorite 0
quote 0
you bought more amgen. it is the best performing dow stock this month up 18%, but it's not -- look, health care has done well. from the april lows, it's up 5%. but it's not tech. it's not utilities. it's not staples. it's not real estate. it's in health care. why? >> i think you want to look for things that haven't moved and that's the thesis we have with most of our trades. can the market go higher? is rick right? i think the markets can go higher, and they can go higher for a lot of reasons, to jenny's point with earnings, that's incredibly important. that's why we bought amgen. horizon therapeutics, talking double digit revenue growth, double digit earnings growth. just an incredible pipeline, so it's these sectors that haven't moved that i think create opportunities. >> you had duke energy called away. you can address that now if you want to. we talk about the things you're in and what drives you in the way you trade using options and covered calls and things like that. you got that called away. >> they
you bought more amgen. it is the best performing dow stock this month up 18%, but it's not -- look, health care has done well. from the april lows, it's up 5%. but it's not tech. it's not utilities. it's not staples. it's not real estate. it's in health care. why? >> i think you want to look for things that haven't moved and that's the thesis we have with most of our trades. can the market go higher? is rick right? i think the markets can go higher, and they can go higher for a lot of...
0
0.0
May 3, 2024
05/24
by
CNBC
tv
eye 0
favorite 0
quote 0
amgen seeing the best day sin 2009 after a big earnings beat, also announcing the injectable obesity drug is expected to be released later this year. >>> a strong week in asia, up.5% against the dollar, bouncing back from a 43-year low. >>> chinese tech ripping higher, the highest level since august. >>> in the meantime, apple's bounce gave a boost to berkshire hat hathaway. shares are up nearly 600% since they started buying the stock. 60% of the portfolio, "wall street journal" asks, is apple becoming one of the riskiest investments in that portfolio. gregory, great to have you with us. why so risky? just because of concentration? >> it's an expensive stock, we know about the growth issues, and yeah, they have over 40% of their portfolio in one stock, so one can have concerns. >> back in february berkshire hathaway trimmed, and that created speculation that they were fur sell shares. it doesn't seem like response portfolio management to have such a concentration. >> listen, farther be it from me to criticize warren buffett, but that's a big concentration. the crop-argument is what
amgen seeing the best day sin 2009 after a big earnings beat, also announcing the injectable obesity drug is expected to be released later this year. >>> a strong week in asia, up.5% against the dollar, bouncing back from a 43-year low. >>> chinese tech ripping higher, the highest level since august. >>> in the meantime, apple's bounce gave a boost to berkshire hat hathaway. shares are up nearly 600% since they started buying the stock. 60% of the portfolio,...
0
0.0
tv
eye 0
favorite 0
quote 0
dow bulls are treading on track for longest winning streak since d ecember 19th and led by boeing, am amgen, cisco and jp morgan and dow up 120 and getting it there, not one at the top of the dow and nestled into the top ten best performers is microsoft. president joe biden juicing up the tech giant's big investment in artificial intelligence during a campaign visit to racine, wisconsin, it's a live picture of the president there at a campaign event talking to voters in the battleground state. biden along with microsoft president brad smith announced a $3.3 billion investment to build a new ai data center, but also a training center for it in the city of racine. let's go live to fox business' edward lawrence in wisconsin right now following the president's every step in the badger state. microsoft is kind of one of the last companies i would say that needs that much money so there's got to be another jobs component to this; right? reporter: yeah and the president is from this area and trying to get jobs back to the area and the president was highlighting the spending he was doing and latchi
dow bulls are treading on track for longest winning streak since d ecember 19th and led by boeing, am amgen, cisco and jp morgan and dow up 120 and getting it there, not one at the top of the dow and nestled into the top ten best performers is microsoft. president joe biden juicing up the tech giant's big investment in artificial intelligence during a campaign visit to racine, wisconsin, it's a live picture of the president there at a campaign event talking to voters in the battleground state....
0
0.0
tv
eye 0
favorite 0
quote 0
apple and amgen and apple with the giant buyback. that is all forward-looking. apple stock, need to keep that in mind, as far as interest rates, got to depend on what surrounds it. the economy looks like it will be in trouble. that could be a negative. neil: i don't see it in the trouble stage. >> the market has been remarkable. neil: talking about the economy. >> it is on balance terrific. as far as the stock market, it is all earnings, the fed will do what they want to do. they have been terrific and the market, almost defies description climbing the proverbial worry. the answer is yes, you have the middle east, you have ukraine, what's going on in the colleges, dysfunction here. you can make a great case, and that is what the short-term treasuries satisfy because you can purchase short-term treasuries. to sleep at night. neil: that is a nice thing to have the job is good seeing you. he is an institution. he's the real article there. touched on the other noise for the markets, this has been every day, got a new update on this. the new york police department ca
apple and amgen and apple with the giant buyback. that is all forward-looking. apple stock, need to keep that in mind, as far as interest rates, got to depend on what surrounds it. the economy looks like it will be in trouble. that could be a negative. neil: i don't see it in the trouble stage. >> the market has been remarkable. neil: talking about the economy. >> it is on balance terrific. as far as the stock market, it is all earnings, the fed will do what they want to do. they...
0
0.0
May 17, 2024
05/24
by
CNBC
tv
eye 0
favorite 0
quote 0
amgen says they will continue pursuing other studies that could allow the drug to be first used as a first line treatment. some pretty amazing -- i guess the merck drug is amazing. >> and the justice department formally began the process of classifying marijuana as less dangerous drug to schedule 3 from schedule 1. yesterday's notice triggers a 60 day comment period. it could take anywhere from a few months to a year but of course puts all these companies in a better position with the banking system and other parts of our economy. some story of my life. now i have no interest in it anymore, it is legal. >> if you had any interest in it. >> it has been a while. but if there had -- at one point if you could walk into a store and buy -- have like aselection of the really greatest -- so coming up meme stocks on the move again. we'll talk about the wild week for gamestop and amc. but next former atlanta fed president dennis lockhart will join us. trading at schwab is now powered by ameritrade, giving traders even more ways to sharpen their skills with tailored education. get an expanding
amgen says they will continue pursuing other studies that could allow the drug to be first used as a first line treatment. some pretty amazing -- i guess the merck drug is amazing. >> and the justice department formally began the process of classifying marijuana as less dangerous drug to schedule 3 from schedule 1. yesterday's notice triggers a 60 day comment period. it could take anywhere from a few months to a year but of course puts all these companies in a better position with the...
0
0.0
May 7, 2024
05/24
by
CNBC
tv
eye 0
favorite 0
quote 0
right now, the sentiment, especially with amgen last week coming out with their own glp-1 offering, that is getting a lot of attention in the short term. >> a lot of things that look interesting in healthcare. united therapeutics, find the one stock that grows faster with higher margins? there is some dislocations underneath i am hitting my screen, there is some stuff on sale. i should be paying attention to set up for 2025 >> given your clientele, you spoke to a growth manager, presumably a reasonably well known one, we are coming out of milken in l.a., hard-to-find pessimism, usually they are negative on the market, are the clients you are talking to, are they optimistic on where we are or not? >> more balance the negative. the ones with big piles of money, i do asset allocation, will always be more negative. i think shannon and i are centered around the headspace. when you go to milken, i have been a couple times, you should feel good about life, you are in the waldorf in beverly hills. you see famous people at every entry and learning interesting things from interesting people. >> yo
right now, the sentiment, especially with amgen last week coming out with their own glp-1 offering, that is getting a lot of attention in the short term. >> a lot of things that look interesting in healthcare. united therapeutics, find the one stock that grows faster with higher margins? there is some dislocations underneath i am hitting my screen, there is some stuff on sale. i should be paying attention to set up for 2025 >> given your clientele, you spoke to a growth manager,...
0
0.0
May 2, 2024
05/24
by
CNBC
tv
eye 0
favorite 0
quote 0
. >> amgen is doing the first human trials and expected to have results in june i want to talk about something else regulation you are shaking your head. in the u.s., regulators accusing novo nordisk and a bunch of other drugmakers, to be fair, for having fake patented that won't hold up to scrutiny. how much of a risk is this >> it is typical for the ftc to put out a list of fake patent. the patents are massive. many patents covering them i think this is really just a bit of non-news. >> non-news? doesn't it raise the risks of generics entering the market which would reduce price and take market share? >> when a drug gets approved, there are lots of patents. typical patents are 100 to 150 covering formulation and how it works. those are not being challenged here i don't think this brings a risk of generics. that will come in the 2030s. we need to watch out for the long term. that is why the pipeline is important. >> we had an analyst on yesterday that said just about everybody will be on them sooner or later. >> current estimates are about 1 billion people in the world live with obe
. >> amgen is doing the first human trials and expected to have results in june i want to talk about something else regulation you are shaking your head. in the u.s., regulators accusing novo nordisk and a bunch of other drugmakers, to be fair, for having fake patented that won't hold up to scrutiny. how much of a risk is this >> it is typical for the ftc to put out a list of fake patent. the patents are massive. many patents covering them i think this is really just a bit of...
0
0.0
May 3, 2024
05/24
by
BLOOMBERG
tv
eye 0
favorite 0
quote 0
amgen surging in the premarket thanks to their push into obesity drugs. the ceo says that he was encouraged by a trial of their experimental obesity drug. if approved amgen said that patients would use a hand-held autoinjector once a month or even less frequently -- less frequent single injections. ozempic you need to take once weekly. that potential competition has sent novo shares down 4% this morning. jonathan: she won't confirm or deny. appreciate it. payrolls come in the most important since the last until the next one. lisa: basically every time. i love how analysts say that it is one number in a number of numbers. some of the commentary on the street is it will be wild, expect huge vol. jonathan: that should be the promo for the next 15 or 20 minutes. it will be wild at: 30 p.m. eastern the jobs report is just around the corner. >> the unemployment rate has been below 4% for two years. as the process of normalization continues, it is hard to get worried about how it is evolving. jonathan: live from new york city, good morning. ♪ jonathan: the sco
amgen surging in the premarket thanks to their push into obesity drugs. the ceo says that he was encouraged by a trial of their experimental obesity drug. if approved amgen said that patients would use a hand-held autoinjector once a month or even less frequently -- less frequent single injections. ozempic you need to take once weekly. that potential competition has sent novo shares down 4% this morning. jonathan: she won't confirm or deny. appreciate it. payrolls come in the most important...
0
0.0
May 16, 2024
05/24
by
FBC
tv
eye 0
favorite 0
quote 0
there's 30 stocks in the dow, big winners, salesforce, home depot, amgen, merck and united health. now show me treasury yields, specifically the 2-year treasury. way below the 5% level which it had approached not too long ago. that downside move in that treasury yield is very good news for stock investors. we'll also get back to this, president biden says he has accepted an invitation to debateup donald trump. trump responded immediately and says, yep, he's going to be there june 27th. now rfk jr. is weighing in. he says, quote, trump and biden are colluding to lock america into a matchup that 70 said they don't want -- 70% don't want. went on to say they're trying to exclude him, rfk jr., because they are afraid he will win. okay. that's the latest on the debate. breaking news today. >>> coming up, a new report says chinese espionage group used mall wear to spy on cargo shipping around the world. we'll bring you the late owens that. >>> the prosecution's star witness, michael cohen, took the stand in trump's criminal trial. what did former florida attorney general pam bondi make o
there's 30 stocks in the dow, big winners, salesforce, home depot, amgen, merck and united health. now show me treasury yields, specifically the 2-year treasury. way below the 5% level which it had approached not too long ago. that downside move in that treasury yield is very good news for stock investors. we'll also get back to this, president biden says he has accepted an invitation to debateup donald trump. trump responded immediately and says, yep, he's going to be there june 27th. now rfk...
0
0.0
May 17, 2024
05/24
by
FBC
tv
eye 0
favorite 0
quote 0
amgen down despite really positive news from the fda on one of its cancer drugs for lung cancer. stock's down $2 right now. it's the biggest drag. "claman count countdown" coming right back. ♪ >> finish morikawa on 18. he is really boxed in here. -not a good spot. off the comcast business van. into the vending area. oh, not the fries! where's the ball? -anybody see it? oh wait, there it is! -back into play and... aw no, it's in the water. wait a minute... -alligator. are you kidding me? you got to be kidding me. rolling towards the cup, and it's in the hole! what an impossible shot brought to you by comcast business. moving forward with node-positive breast cancer. my fear of recurrence could've held me back. but i'm staying focused. and doing more to prevent recurrence. verzenio is specifically for hr-positive, her2-negative, node-positive early breast cancer with a high chance of returning, as determined by your doctor when added to hormone therapy. verzenio reduces the risk of recurrence versus hormone therapy alone. diarrhea is common, may be severe, or cause dehydration or
amgen down despite really positive news from the fda on one of its cancer drugs for lung cancer. stock's down $2 right now. it's the biggest drag. "claman count countdown" coming right back. ♪ >> finish morikawa on 18. he is really boxed in here. -not a good spot. off the comcast business van. into the vending area. oh, not the fries! where's the ball? -anybody see it? oh wait, there it is! -back into play and... aw no, it's in the water. wait a minute... -alligator. are you...
0
0.0
May 22, 2024
05/24
by
CNBC
tv
eye 0
favorite 0
quote 0
health care sector, it's a sector i want to continue to build positioning in recently, i bought merck, amgen, and other names i'm looking at. >> striker upgraded today to buy. that's it. needham, price target to $392. >> very solid revenue growth for stryker. i think also about the glp-1 phenomenon and all the eligibility for folks that once were not eligible for different joint replacements and surgeries that now are because of the advent of glp-1, i think that's where stryker plays. >> chipotle price target raised to $3,485, from 3,300 at oppenheimer, rereiterated, out perform, what do you think >> i think it could get there ahead of the 50-1 stock split. for the viewers, that's of june 18th the date of record, and then june 25th, it actually gets affected be careful here. it's getting a little bit rich on a valuation perspective, and also looking at a recent 13 f, bill ackman in pershing square reduced their position in chipotle by 10%. now, he still owns 740,000 shares, and you have to acknowledge, this is probably one of the best trades that bill ackman has had owning chipotle over the
health care sector, it's a sector i want to continue to build positioning in recently, i bought merck, amgen, and other names i'm looking at. >> striker upgraded today to buy. that's it. needham, price target to $392. >> very solid revenue growth for stryker. i think also about the glp-1 phenomenon and all the eligibility for folks that once were not eligible for different joint replacements and surgeries that now are because of the advent of glp-1, i think that's where stryker...
0
0.0
tv
eye 0
favorite 0
quote 0
and finally, amgen also driving the dow higher today. the pharmaceutical company also served investors a strong earnings report and the muse that their obesity injection drug is proceeding ahead to phase two trials. they closed up to close to 12%. another thing, larry, the cm if e fed watch tool, i just checked it, it's predicting that at rate cut comes in september but, listen, we get economic day data every week. we've seen good and bad signs, so let's not celebrate until we have more data points. larry: right. kelly o'grady, thanks very much. now my riff. on wednesday, back on wednesday, president donald trump gave a barn burner of a speech in wisconsin laying out his future economic agenda such as strict the federal spending controls, extending the successful trump tax cuts, drill, baby, drill and other deregulation measures. it's the sort of thing that could launch another trump economic boom, especially for working class americans. joe biden, on the other hand, has a future agenda that includes roughly a $5 trillion tax hike, feder
and finally, amgen also driving the dow higher today. the pharmaceutical company also served investors a strong earnings report and the muse that their obesity injection drug is proceeding ahead to phase two trials. they closed up to close to 12%. another thing, larry, the cm if e fed watch tool, i just checked it, it's predicting that at rate cut comes in september but, listen, we get economic day data every week. we've seen good and bad signs, so let's not celebrate until we have more data...
0
0.0
May 28, 2024
05/24
by
FBC
tv
eye 0
favorite 0
quote 0
the blue chips at the moment losing 3298 points -- 298 points led lower by merck and amgen. no real news on either of these stocks, but moderna is getting slashed and is the worst performer on both the s&p and the nasdaq 1000. no moderna falling about a 9.6%. no real headlines there either, but after 10 straight sessions of gains, no surprise we're seeing some profit taking in that name p. so stocks may be move being on little to no headlines, but nail-biter news is coming this week. we've got two major, potentially market-moving data points; namely, the first revision of first quarter gdp. that's thursday. and then friday, the big kahuna, the federal reserve's favorite inflation gauge, core pce for the month of april. and while we're almost done with first quarter earnings season, some retail heavyweights are about to report their numbers. among them, dick's sporting goods, abercrombie & fitch, kohl's, best buy, foot locker, gap stores, all that and and nordstrom. been ulta. one name reigns supreme this session with let's call it 58 minutes left to trade, a.i. chip leader n
the blue chips at the moment losing 3298 points -- 298 points led lower by merck and amgen. no real news on either of these stocks, but moderna is getting slashed and is the worst performer on both the s&p and the nasdaq 1000. no moderna falling about a 9.6%. no real headlines there either, but after 10 straight sessions of gains, no surprise we're seeing some profit taking in that name p. so stocks may be move being on little to no headlines, but nail-biter news is coming this week. we've...
0
0.0
tv
eye 0
favorite 0
quote 0
i see just 2 losers, amgen, mcdonald's and 3m. three losers, there you go. the s&p 500, how's that opened in up 36 points, that's .73%, solid. the nasdaq composite, it is up 151 points, almost 11%. very -- 1%. very solid. show me big tech, please. any significant rebound there? not bad. apple up $2. amazon, microsoft still below $4000. alphabet, 164. meta, though, is down $2. i want to single out apple for a moment. lauren, what are the analyst -- i hate the expectationses game. what are they looking for? lauren: so i spent some time this morning, because i didn't want to publicly ask the question because i didn't want to appear that dumb, i was going to ask rob and stephen, are there a.i. foetures right now in the iphone? >> not really. lauren: there's not, okay. >> spell check. kind of sort of. lauren: we might get that in june, june 10th is the developers' conference, and next week tim cook is going to hint at what you will see in iphone 16 andish s os -- ios 16 is. you say india's pig? sales -- big? sales are down in china, $45 billion of their overall a
i see just 2 losers, amgen, mcdonald's and 3m. three losers, there you go. the s&p 500, how's that opened in up 36 points, that's .73%, solid. the nasdaq composite, it is up 151 points, almost 11%. very -- 1%. very solid. show me big tech, please. any significant rebound there? not bad. apple up $2. amazon, microsoft still below $4000. alphabet, 164. meta, though, is down $2. i want to single out apple for a moment. lauren, what are the analyst -- i hate the expectationses game. what are...
11
11
May 24, 2024
05/24
by
CSPAN
tv
eye 11
favorite 0
quote 1
. >> welcome the ceo of amgen kenya. >> thank you very much. i have, should i say, the fortune of being the last speaker today. my role is to basically give a vote of thanks. for your excellencies, distinguished guests, ladies and gentlemen. on behalf of the leadership of the u.s. chamber, i extend our heartfelt gratitude for your presence at this landmark u.s. kenya business forum. today event, building on the recent amcham business summit in nairobi marks a significant step forward in the kenya u.s. commercial partnership. president ruto, vice president harris, and secretary raimondo, who have spoken just before me, your attendance has caused a deep bond between our nations and commitment to fostering economic prosperity and cooperation. thank you for honoring us with your presence. this morning and this afternoon. to all of our distinguished speakers, thank you for sharing your expertise and lighting the way for enhanced bilateral trade and investment. finally, a very special thank you to our part -- sponsors for the general support. your co
. >> welcome the ceo of amgen kenya. >> thank you very much. i have, should i say, the fortune of being the last speaker today. my role is to basically give a vote of thanks. for your excellencies, distinguished guests, ladies and gentlemen. on behalf of the leadership of the u.s. chamber, i extend our heartfelt gratitude for your presence at this landmark u.s. kenya business forum. today event, building on the recent amcham business summit in nairobi marks a significant step...
0
0.0
May 17, 2024
05/24
by
FBC
tv
eye 0
favorite 0
quote 0
stuart: amgen got a big boost from the fda, their drug to treat lung cancer was approved. what many do you have? lauren: i know, and it treats the most deadly form most common in smokers, it reduces tumor growth. and then the patients live longer. so typically, it's a death sentence. a sur rival rate of five months -- survival rate of five months. that's good news. stock is down, nonetheless. stuart: got it. let's yet to the meme stocks. they've had quite a week. i notice they're all down again today. recap the week, please. lauren: can i give you the news on gamestop first? it's down the most, 24, right now -- 24%. they just pre-reported, if you will. we expect our first quarter sales to fall pretty sharply from a year ago because customers, stating the obvious, don't go into a brick and mortar to buy their video games anymore, right? so the fundamentals of that company aren't doing so well. they're also selling up to 45 million shares to take advantage of the meme stock frenzy this week. so monday and tuesday stock jumped more than that that, on the week it's up sharply,
stuart: amgen got a big boost from the fda, their drug to treat lung cancer was approved. what many do you have? lauren: i know, and it treats the most deadly form most common in smokers, it reduces tumor growth. and then the patients live longer. so typically, it's a death sentence. a sur rival rate of five months -- survival rate of five months. that's good news. stock is down, nonetheless. stuart: got it. let's yet to the meme stocks. they've had quite a week. i notice they're all down again...
0
0.0
May 15, 2024
05/24
by
CNNW
tv
eye 0
favorite 0
quote 0
. >> that's all i had health this morning, brought to you by amgen learn more about disease at is it you were diagnosed with thyroid eye disease along time ago and year after year, you weathered the storm and just lived with the damage that was left behind. >> but even after all this time your thyroid eye disease it's could still change restoration is still possible learn how you could give your eyes a fresh start at ted help.com arthritis, pain. >> we say not today tylenol, eight hour arthritis pain has two layers of relief. >> the first is fast, the second is long-lasting we give you your day back, so you can give it everything. tylenol number one, doctor recommended birthright is paying. >> this will be a goldmine of local intel, just you wait. >> so tell us about this corn festival. he got your corn pudding. you've got your core on chowder. it's how is it safe for anterior sometimes the family of eight were to need a cold punch. >> where would they find it? >> then they give it in better and bam, it goes right really two vampire bar like remal deselect, a blessing on the call mor
. >> that's all i had health this morning, brought to you by amgen learn more about disease at is it you were diagnosed with thyroid eye disease along time ago and year after year, you weathered the storm and just lived with the damage that was left behind. >> but even after all this time your thyroid eye disease it's could still change restoration is still possible learn how you could give your eyes a fresh start at ted help.com arthritis, pain. >> we say not today tylenol,...
0
0.0
May 22, 2024
05/24
by
CNNW
tv
eye 0
favorite 0
quote 0
rising to the ranks of michael jordan in one key metric already hello, this morning, brought to you by amgen learn more about thyroid disease at, is it ted.com you, were diagnosed with thyroid? disease a long time ago and year after year, you weathered the storm and just lived with the damage that was left behind? but even after all this time, your thyroid eye disease could still change restoration is still possible learn how you could give your eyes a fresh start at ted help.com they say we should stop eating so much meat so we made meet out of plants because we aren't quitters impossible. >> we're solving the meat problem with more meat. listen, i can't go into this ipo blindly. how do we make sure we're ready to meet all regulatory requirements? chris that is a great question steve. >> it's an important question. >> tyler. >> i'd even say a critical question three, with tyler. terrific. >> glad i asked we need to ask markup ever wonder where the people with all the the answers get all the answers. ask marcum, accountants and advisers. >> this home-style chicken salad ran from subway. >> t
rising to the ranks of michael jordan in one key metric already hello, this morning, brought to you by amgen learn more about thyroid disease at, is it ted.com you, were diagnosed with thyroid? disease a long time ago and year after year, you weathered the storm and just lived with the damage that was left behind? but even after all this time, your thyroid eye disease could still change restoration is still possible learn how you could give your eyes a fresh start at ted help.com they say we...
0
0.0
May 21, 2024
05/24
by
CNNW
tv
eye 0
favorite 0
quote 0
just hours before his second round tee time at the pga championship the good stuff brought to you by amgen. learn more about thyroid disease at, is it? ted.com if you have graves disease, gritty eyes could be more than a rough patch. >> people with graves could also get thyroid eye disease or ted, which may need a different i'm dr. find a ted is specialist at is it ted.com this is pickleball is basically tenants for babies, but for adults, it should be called willful tennis like a pr we have nothing to worry about with e-trade for morgan stanley were ready for whatever gets served up to you, get a work on your chest. >> i'd rather work on saving for retirement for college since we'd like to get schooled, has pretty good burn, right? >> got game thanks for coming to our clinic. >> first one's free. >> so how long have you lived here? >> 40 years. >> and how or the restaurants around here? are they good, bad man what's the average household income? >> is there a mall? i don't know. a hair salon. where do you get your hair done can you a little what we've got to go thousand more parts we brin
just hours before his second round tee time at the pga championship the good stuff brought to you by amgen. learn more about thyroid disease at, is it? ted.com if you have graves disease, gritty eyes could be more than a rough patch. >> people with graves could also get thyroid eye disease or ted, which may need a different i'm dr. find a ted is specialist at is it ted.com this is pickleball is basically tenants for babies, but for adults, it should be called willful tennis like a pr we...
0
0.0
May 10, 2024
05/24
by
CNNW
tv
eye 0
favorite 0
quote 0
minute now is day 15 of his criminal trial is about to get underway the good stuff brought to you by amgen. >> learn more about thyroid disease at is it ted.com if you have graves disease, gritty eyes could be more than a rough patch people with graves could also get thyroid eye disease or ted, which may need a different doctor. >> find a ted is specialist at is-it ted.com? >> when your business throws you a surprise, don't throw in the towel with funding, you can count on biz to credit, makes it simple and convenient to solve problems. you never saw coming. when trouble bruise, viz to credit is the solution. this to credit funding. what's next? >> higher shipping race may be the cost of doing business. but at what cost turns shipping to your advantage with low cost ground shipping? from the united states postal service raising you was no better frozen. are you getting me anything for mother's day? >> go to one 800 flowers.com gorgeous. i feel like we're lt what 800 flowers.com i'm happy mother's day. happy mother's day with robin hood gold. >> you can make your money, do the most, made yo
minute now is day 15 of his criminal trial is about to get underway the good stuff brought to you by amgen. >> learn more about thyroid disease at is it ted.com if you have graves disease, gritty eyes could be more than a rough patch people with graves could also get thyroid eye disease or ted, which may need a different doctor. >> find a ted is specialist at is-it ted.com? >> when your business throws you a surprise, don't throw in the towel with funding, you can count on biz...
0
0.0
May 3, 2024
05/24
by
CNNW
tv
eye 0
favorite 0
quote 0
brought to you by amgen. learn more about thyroid disease at, is it ted.com if you have graves disease and blurry vision, you need clear answers. >> people with graves could also get thyroid hi disease or ted, which may need a different doctor find a ted is specialist at is-it ted.com tan phi one shot super, super 20 right? >> i love shopping the real real gucci, louis vuitton yard, debris sandler on luxury brands, up to 90% off retail. >> thousands of new arririvals daily the real, real sometimes investing can feel like you're going at it alone especially when it comes to adding crypto to your portfolio. but it doesn't have to be that way as the world's largest crypto asset manager, you'll find a lot of people holding grayscale funds which means you're investing in good company grayscale crypto investing begins here from tried and true to try something new so many ways to save life, ready wallet, happy. >> that's 3605 by whole foods market, we handcraft every stearns and foster using the finest materials lik
brought to you by amgen. learn more about thyroid disease at, is it ted.com if you have graves disease and blurry vision, you need clear answers. >> people with graves could also get thyroid hi disease or ted, which may need a different doctor find a ted is specialist at is-it ted.com tan phi one shot super, super 20 right? >> i love shopping the real real gucci, louis vuitton yard, debris sandler on luxury brands, up to 90% off retail. >> thousands of new arririvals daily the...
0
0.0
May 9, 2024
05/24
by
CNNW
tv
eye 0
favorite 0
quote 0
the glee in new york when the knicks went to whole playoff games in the good stuff brought to you by amgen learn more about thyroiditis at, is it ted.com if you have graves disease gritty eyes could be more than a rough patch. people with graves could also get thyroid eye disease or ted, which may need a different doctor, find a ted is specialist at is it ted.com? >> shut that's the until may 12th for up to 30% off special mother's day gifts that go beyond the usual suspects, save on personalized jewelry, original decor, and other things. moms actually love when you need a gift is unique because she is that's he has from tried and true to try something new so many ways to save life ready wallet, happy. that 360 b5 by whole foods market. >> chances for plane crash one million. you're not continues to assault tonight's right never waking up from anesthesia one and 185,000 valley, your parking or to see how customer by stress about the unlikely does a killer clown worry about being struck by lightning while winning the lottery, sheared out. but your odds of falling victim the online crime are
the glee in new york when the knicks went to whole playoff games in the good stuff brought to you by amgen learn more about thyroiditis at, is it ted.com if you have graves disease gritty eyes could be more than a rough patch. people with graves could also get thyroid eye disease or ted, which may need a different doctor, find a ted is specialist at is it ted.com? >> shut that's the until may 12th for up to 30% off special mother's day gifts that go beyond the usual suspects, save on...
0
0.0
May 8, 2024
05/24
by
CNNW
tv
eye 0
favorite 0
quote 0
details on his jarring and in pretty bizarre health admission health this morning brought to you by amgen learn more about thyroid eye disease at, izzat ted.com if you have graves disease and blurry vision, you need clear answers. people with graves could also get i would i'd disease he's or ted, which may need a different doctor, find a ted is specialist at is it ted.com there piece of evidence tells a story how we really haven't. >> jesse el mont'e sunday's at night on cnn new lives, the hot pro massaging bone, easy to grip the massage and the power of to mac strength pain relievers is works for as he makes it less new i see hot probe massaging boehm if you have chronic kidney disease, you can reduce the risk of kidney failure with bar sega because they're places you'd like to be for circular can cause serious side effects, including ketoacidosis that may be fatal dehydration, urinary tract, or genital yeast infections low blood sugar, a rare life-threatening bacterial infection in the skin of the perineum could occur, stopped taking for sika and call your doctor right away if you have
details on his jarring and in pretty bizarre health admission health this morning brought to you by amgen learn more about thyroid eye disease at, izzat ted.com if you have graves disease and blurry vision, you need clear answers. people with graves could also get i would i'd disease he's or ted, which may need a different doctor, find a ted is specialist at is it ted.com there piece of evidence tells a story how we really haven't. >> jesse el mont'e sunday's at night on cnn new lives,...
0
0.0
May 29, 2024
05/24
by
CNNW
tv
eye 0
favorite 0
quote 1
and once pristine rivers now orange it's all because of climate hello, this morning brought to you by amgen learn more about thyroid disease at is it ted.com? >> if you have graves disease, your eye symptoms could mean something more than gritty feeling can be brushed away even a little blurry vision can distort things. and something serious, may be behind those itchy eyes up to 50% of people with graves could develop a different condition called thyroid eye disease, which should be treated by a different doctor. see an expert, find a ted is specialist at is-it ted.com so the irs is auditing your company happened to me a couple of months ago. it was nothing i asked mark them ever wonder where the people with all the answers get all the answers. >> ask markham, accountants and advisers, what will you do when the power goes out power outages can be unpredictable and inconvenient but with a generale home standby generator, your life goes on uninterrupted because you have power when you need it the most number one thing you prepare for his extended the power outages, don't make it so hard on yo
and once pristine rivers now orange it's all because of climate hello, this morning brought to you by amgen learn more about thyroid disease at is it ted.com? >> if you have graves disease, your eye symptoms could mean something more than gritty feeling can be brushed away even a little blurry vision can distort things. and something serious, may be behind those itchy eyes up to 50% of people with graves could develop a different condition called thyroid eye disease, which should be...
0
0.0
May 6, 2024
05/24
by
CNBC
tv
eye 0
favorite 0
quote 0
i don't know about your compadre there, but i think lilly may be going up because people realize amgen is not about to put something in the market. >> that's well said. >> it's a great thought, and i think your person -- that's very important. >>> meantime, as we go to break, as we said, 5,157 is going to be at a three-week high on the s&p. every sector, green, except for staples, down just a touch. ten-year, still circulating, 4.5%. not a lot of fed speak. tonight, we'll get barkin and williams, this afternoon, but for the week, it's mostly about jobless claims on friday. after last month's massive solar flare added a 25th hour to the day, businesses are wondering "what should we do with it?" bacon and eggs 25/7. you're darn right. solar stocks are up 20% with the additional hour in the day. [ clocks ticking ] i'm ruined. with the extra hour i'm thinking companywide power nap. let's put it to a vote. [ all snoring ] this is going to wreak havoc on overtime approvals. anything can change the world of work. from hr to payroll, adp designs forward-thinking solutions to take on the next a
i don't know about your compadre there, but i think lilly may be going up because people realize amgen is not about to put something in the market. >> that's well said. >> it's a great thought, and i think your person -- that's very important. >>> meantime, as we go to break, as we said, 5,157 is going to be at a three-week high on the s&p. every sector, green, except for staples, down just a touch. ten-year, still circulating, 4.5%. not a lot of fed speak. tonight,...
SFGTV: San Francisco Government Television
0
0.0
May 8, 2024
05/24
by
SFGTV
tv
eye 0
favorite 0
quote 0
i amgen fer casarian and i work here at san francisco international airport. the idea for therapy dogs got started the day after 9/11. an employee brought his therapy dog to work after 9/11 and he was able to see how his dog was able to relieve passenger's jitter. when we first launched the program back in 2013, our main goal was to destress our passengers however what we quickly found is that our animals were helping us find a way to connect with our pang. passengers. we find there are a lot of people traveling through the airport who are missing their pets and who are on their road a lot and can't have pets and we have come in contact with a lot of people recently who have lost pet. >> i love the wag brigade. >> one of my favorite parts is walking into the terminals and seeing everybody look up from their device, today everybody is interacting on their cell phone or laptop and we can walk into the terminal with a dog or a pig and people start to interact with each other again and it's on a different level. more of an emotional level. >> i just got off an 11.
i amgen fer casarian and i work here at san francisco international airport. the idea for therapy dogs got started the day after 9/11. an employee brought his therapy dog to work after 9/11 and he was able to see how his dog was able to relieve passenger's jitter. when we first launched the program back in 2013, our main goal was to destress our passengers however what we quickly found is that our animals were helping us find a way to connect with our pang. passengers. we find there are a lot...
0
0.0
May 6, 2024
05/24
by
CNBC
tv
eye 0
favorite 0
quote 0
and the amgen news from last week. we'll be right back. (grunting) >> announcer: this cnbc program is sponsored by baird. visit bairddifference.com. meets bold new thinking. (laughter) at 88 years old, we still see the world with the wonder of new eyes, helping you discover untapped possibilities and relentlessly working with you to make them real. old school grit. new world ideas. morgan stanley. at pgim, finding opportunity in fixed income today, helps secure tomorrow. our time-tested fixed income suite, backed by over 145 years of risk experience, helps investors meet their goals. pgim investments. shaping tomorrow today. and they're all coming? pgim investments. those who are still with us, yes. grandpa! what's this? your wings. light 'em up! gentlemen, it's a beautiful... ...day to fly. when you automate sales tax with avalara, you don't have to worry about things like changing tax rates or filing returns. avalarahhh ahhh >>> our next guest feels investors are still too cautious, but he thinks the fear of may or the sell in may and go
and the amgen news from last week. we'll be right back. (grunting) >> announcer: this cnbc program is sponsored by baird. visit bairddifference.com. meets bold new thinking. (laughter) at 88 years old, we still see the world with the wonder of new eyes, helping you discover untapped possibilities and relentlessly working with you to make them real. old school grit. new world ideas. morgan stanley. at pgim, finding opportunity in fixed income today, helps secure tomorrow. our time-tested...
0
0.0
May 23, 2024
05/24
by
CNBC
tv
eye 0
favorite 0
quote 0
that is roughly the size of adding an entire dow component like amgen or verizon at opening bell nvidia top of the town a.i. coat tails catching other tech companies pre-market gains for other computer chip makers, micro devices, broadcom and others as well high-end computer server makers, super microcomputer as well. even in positivity for digital real estate companies. right? data center companies. look at those names. digital realty 1.25% as well cap things off with the enterprise technology space ecosystem as well. a couple analysts calls helping to add tailwinds to more than just nvidia's tailwinds. dell and enterprise getting both added to the tactical outperform lichte of evercore ahead of respective earnings report expecting better than expected results for prints in both for more and other top analyst calls head to cnbc.com/pro subscribers get more details, analysis in those stories, mike. nvidia, tech, the whole ecosystem all up going to be the talk for a while. sends it back to you. >> fascinating, dom. center considering jensen wang after the earnings report yesterday pointe
that is roughly the size of adding an entire dow component like amgen or verizon at opening bell nvidia top of the town a.i. coat tails catching other tech companies pre-market gains for other computer chip makers, micro devices, broadcom and others as well high-end computer server makers, super microcomputer as well. even in positivity for digital real estate companies. right? data center companies. look at those names. digital realty 1.25% as well cap things off with the enterprise technology...